Advancing the systemic therapy of lung cancer: quality or quantity?

Lancet Oncol. 2020 Mar;21(3):322-324. doi: 10.1016/S1470-2045(20)30076-0. Epub 2020 Feb 6.

Authors

Andrea S Fung¹, Natasha B Leighl²

Affiliations

¹ Division of Medical Oncology/Hematology, Princess Margaret Cancer Centre, University of Toronto, ON M5G 1Z5, Canada.
² Division of Medical Oncology/Hematology, Princess Margaret Cancer Centre, University of Toronto, ON M5G 1Z5, Canada. Electronic address: natasha.leighl@uhn.ca.

PMID: 32035512
DOI: 10.1016/S1470-2045(20)30076-0

No abstract available

Publication types

Comment

MeSH terms

Humans
Lung Neoplasms*